Cargando…
In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial
INTRODUCTION: The aim of this work is to evaluate the effect of mesenchymal stem cell transplantation (MSCT) and cultivated limbal epithelial transplantation (CLET) therapies on the limbus of patients suffering from limbal stem cell deficiency (LSCD). METHODS: A sub-analysis of a phase I–II randomiz...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640524/ https://www.ncbi.nlm.nih.gov/pubmed/37773479 http://dx.doi.org/10.1007/s40123-023-00809-7 |
_version_ | 1785146649835732992 |
---|---|
author | Pérez, Inmaculada Galindo, Sara López-Miguel, Alberto Nieto-Miguel, Teresa de la Mata, Ana López-Paniagua, Marina Alberca, Mercedes Herreras, José M. Calonge, Margarita |
author_facet | Pérez, Inmaculada Galindo, Sara López-Miguel, Alberto Nieto-Miguel, Teresa de la Mata, Ana López-Paniagua, Marina Alberca, Mercedes Herreras, José M. Calonge, Margarita |
author_sort | Pérez, Inmaculada |
collection | PubMed |
description | INTRODUCTION: The aim of this work is to evaluate the effect of mesenchymal stem cell transplantation (MSCT) and cultivated limbal epithelial transplantation (CLET) therapies on the limbus of patients suffering from limbal stem cell deficiency (LSCD). METHODS: A sub-analysis of a phase I–II randomized, controlled, and double-masked clinical trial was performed to assess the changes in the anatomical structures of the limbus. In vivo confocal microscopy (IVCM) analysis was carried out in LSCD eyes before and 12 months after allogeneic MSCT or CLET. Epithelial phenotype of the central cornea, as well as the presence of transition zones and palisades of Vogt in the limbus, were assessed using Wilcoxon test. RESULTS: Twenty-three LSCD (14 MSCT and nine CLET) eyes were included. The epithelial phenotype of the central cornea improved significantly (p < 0.001) from 15 (eight MSCT, seven CLET) and eight (six MSCT, two CLET) LSCD eyes showing conjunctival and mixed phenotypes, respectively, to eight (five MSCT, three CLET), five (two MSCT, three CLET), and ten (seven MSCT, three CLET) eyes showing conjunctival, mixed, and corneal phenotypes, respectively. Transition areas and palisades of Vogt were observed in at least one quadrant in nine (five MSCT, four CLET) and 16 (nine MSCT, seven CLET), and in four (two MSCT, two CLET) and six (three MSCT, three CLET) LSCD eyes before and after surgery, respectively. Changes in the transition zones and palisades were solely significant (p = 0.046) for the nasal and inferior quadrants, respectively. CONCLUSIONS: MSCT and CLET improved the central corneal epithelial phenotype despite only minor changes in the anatomical structures of the limbus, as detected by IVCM technology. TRIAL REGISTRATION: ClinicalTrials.gov identifier, NCT01562002. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40123-023-00809-7. |
format | Online Article Text |
id | pubmed-10640524 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-106405242023-11-15 In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial Pérez, Inmaculada Galindo, Sara López-Miguel, Alberto Nieto-Miguel, Teresa de la Mata, Ana López-Paniagua, Marina Alberca, Mercedes Herreras, José M. Calonge, Margarita Ophthalmol Ther Original Research INTRODUCTION: The aim of this work is to evaluate the effect of mesenchymal stem cell transplantation (MSCT) and cultivated limbal epithelial transplantation (CLET) therapies on the limbus of patients suffering from limbal stem cell deficiency (LSCD). METHODS: A sub-analysis of a phase I–II randomized, controlled, and double-masked clinical trial was performed to assess the changes in the anatomical structures of the limbus. In vivo confocal microscopy (IVCM) analysis was carried out in LSCD eyes before and 12 months after allogeneic MSCT or CLET. Epithelial phenotype of the central cornea, as well as the presence of transition zones and palisades of Vogt in the limbus, were assessed using Wilcoxon test. RESULTS: Twenty-three LSCD (14 MSCT and nine CLET) eyes were included. The epithelial phenotype of the central cornea improved significantly (p < 0.001) from 15 (eight MSCT, seven CLET) and eight (six MSCT, two CLET) LSCD eyes showing conjunctival and mixed phenotypes, respectively, to eight (five MSCT, three CLET), five (two MSCT, three CLET), and ten (seven MSCT, three CLET) eyes showing conjunctival, mixed, and corneal phenotypes, respectively. Transition areas and palisades of Vogt were observed in at least one quadrant in nine (five MSCT, four CLET) and 16 (nine MSCT, seven CLET), and in four (two MSCT, two CLET) and six (three MSCT, three CLET) LSCD eyes before and after surgery, respectively. Changes in the transition zones and palisades were solely significant (p = 0.046) for the nasal and inferior quadrants, respectively. CONCLUSIONS: MSCT and CLET improved the central corneal epithelial phenotype despite only minor changes in the anatomical structures of the limbus, as detected by IVCM technology. TRIAL REGISTRATION: ClinicalTrials.gov identifier, NCT01562002. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40123-023-00809-7. Springer Healthcare 2023-09-29 2023-12 /pmc/articles/PMC10640524/ /pubmed/37773479 http://dx.doi.org/10.1007/s40123-023-00809-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Pérez, Inmaculada Galindo, Sara López-Miguel, Alberto Nieto-Miguel, Teresa de la Mata, Ana López-Paniagua, Marina Alberca, Mercedes Herreras, José M. Calonge, Margarita In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial |
title | In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial |
title_full | In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial |
title_fullStr | In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial |
title_full_unstemmed | In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial |
title_short | In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I–II Clinical Trial |
title_sort | in vivo confocal microscopy in limbal stem cell deficiency after mesenchymal stem cell transplantation: a sub-analysis from a phase i–ii clinical trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640524/ https://www.ncbi.nlm.nih.gov/pubmed/37773479 http://dx.doi.org/10.1007/s40123-023-00809-7 |
work_keys_str_mv | AT perezinmaculada invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT galindosara invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT lopezmiguelalberto invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT nietomiguelteresa invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT delamataana invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT lopezpaniaguamarina invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT albercamercedes invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT herrerasjosem invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial AT calongemargarita invivoconfocalmicroscopyinlimbalstemcelldeficiencyaftermesenchymalstemcelltransplantationasubanalysisfromaphaseiiiclinicaltrial |